Biotech’s data supporting Alzheimer’s trials under scrutiny
A law firm known for filing shareholder suits says that data supporting a drug company’s plan for trials of its experimental treatment for Alzheimer’s disease show evidence of manipulation. Stock in the company, Cassava Biosciences, tumbled yesterday after the FDA posted material from the firm, Labaton Sucharow, and a top research integrity expert tells Retraction … Continue reading Biotech’s data supporting Alzheimer’s trials under scrutiny